Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4392 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 4392

To authorize the Secretary of Health and Human Services to award grants 
 to increase early detection of and intervention for uterine fibroids, 
                        and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 15, 2025

   Ms. Brown (for herself, Ms. Clarke of New York, Ms. Sewell, Mrs. 
    Foushee, Ms. McClellan, Ms. Velazquez, Mr. Fields, Ms. Kelly of 
Illinois, Mrs. Dingell, Ms. Tlaib, Mrs. Trahan, Mr. Johnson of Georgia, 
   Ms. Ansari, Mrs. Watson Coleman, Mr. David Scott of Georgia, Mr. 
Thanedar, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Salinas, 
Mrs. McIver, Mr. Carter of Louisiana, Ms. Meng, Ms. Wilson of Florida, 
Ms. Lee of Pennsylvania, Ms. Simon, Ms. Wasserman Schultz, Mr. Figures, 
 Ms. Adams, Mr. Khanna, Ms. Underwood, Mr. Green of Texas, Ms. Tokuda, 
   Ms. Rivas, Mr. Mannion, Ms. Pressley, Ms. Titus, and Mr. Latimer) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To authorize the Secretary of Health and Human Services to award grants 
 to increase early detection of and intervention for uterine fibroids, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Uterine Fibroid Intervention and 
Gynecological Health Treatment Act of 2025''.

SEC. 2. RESEARCH ON UTERINE FIBROID EARLY DETECTION AND INTERVENTION.

    (a) In General.--The Secretary of Health and Human Services (in 
this Act referred to as the ``Secretary'') shall--
            (1) conduct or support research on increasing early 
        detection of, and intervention for, uterine fibroids; and
            (2) based on the results of such research and other 
        relevant information, formulate evidence-based or evidence-
        informed strategies to increase early detection in health care 
        settings.
    (b) Timeline.--The Secretary shall finalize the evidence-based or 
evidence-informed strategies required by subsection (a)(2) as 
expeditiously as possible in order to make such strategies available to 
grantees under section 3 to implement such strategies pursuant to 
section 3(b)(3).

SEC. 3. GRANTS WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND 
              INTERVENTION.

    (a) In General.--The Secretary of Health and Human Services (in 
this Act referred to as the ``Secretary'') may award grants to States 
for carrying out programs--
            (1) to increase early detection of and intervention for 
        uterine fibroids; and
            (2) to develop and implement public awareness and education 
        campaigns for the early detection and intervention of uterine 
        fibroids.
    (b) Use of Funds.--A State receiving a grant under this section may 
use the grant, with respect to increasing early detection of and 
intervention for uterine fibroids, for the following activities:
            (1) Screening procedures, including advanced gynecological 
        imaging (including payment therefor).
            (2) Patient navigation services.
            (3) Implementation of evidence-based or evidence-informed 
        strategies proven to increase early detection in health care 
        settings.
            (4) Facilitating access to health care settings.
    (c) Priority.--In awarding grants under this section, the Secretary 
shall give priority to States proposing to carry out a program in a 
geographic areas in which there are socially vulnerable populations 
with elevated risk of uterine fibroid development.

SEC. 4. RESEARCH WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND 
              INTERVENTION.

    The Secretary may award grants to conduct research, which may 
include clinical trials, related to--
            (1) disparities in pain control and management in uterine 
        fibroid surgical treatment; or
            (2) Asherman's Syndrome, intrauterine adhesions, and other 
        intrauterine conditions as determined appropriate by the 
        Secretary.

SEC. 5. REPORTS TO CONGRESS.

    (a) Reports on Grants.--Not later 2 years after the initial award 
of grants under this Act, and every 2 years thereafter, the Secretary 
shall submit to the Congress, and make publicly available on the 
appropriate website of the Department of Health and Human Services, a 
report summarizing the findings and results of programs and activities 
funded through grants under this Act.
    (b) Report on Research Developments.--Not later than 2 years after 
the date of enactment of this Act, and every 2 years thereafter, the 
Secretary shall submit to the Congress, and make publicly available on 
the appropriate website of the Department of Health and Human Services, 
a report outlining research developments and findings related to--
            (2) disparities in pain control and management in uterine 
        fibroid surgical treatment; and
            (3) Asherman's Syndrome, intrauterine adhesions, and other 
        intrauterine conditions as determined appropriate by the 
        Secretary.
                                 <all>